Cassandra Pardini, PharmD

Contributing Writer

Cassandra Pardini is a freelance writer and registered pharmacist with a diverse background in drug therapy, scientific research, and the drug discovery and developmental process. She obtained her Doctor of Pharmacy degree from the Massachusetts College of Pharmacy and Health Sciences University, Master of Science degree in chemistry and chemical biology from Northeastern University, and Bachelor of Science degree in chemistry from Boston College. She currently lives in Rhode Island with her husband and 3 children.

All articles by Cassandra Pardini, PharmD

General Dermatology

Combination Treatment Appears Beneficial for Chronic Migraine

Cassandra Pardini, PharmD

May 6, 2021

Data analysis revealed that CGRP mAbs were discontinued more frequently than onabotulinumtoxinA (23% vs 3%).

General Dermatology

Case Report Highlights Potential for Severe Infection Following Epinephrine Auto-Injection

Cassandra Pardini, PharmD

May 4, 2021

The 60-year-old male patient presented to the ED complaining of “the worst pain in his life” in his right thigh.

General Dermatology

Potential Drug Interaction Between Warfarin, COVID-19 Treatment Reported

Cassandra Pardini, PharmD

April 29, 2021

The patients, a 71-year-old male and a 62 year-old-male, both on long-term warfarin therapy, presented to the emergency department with symptoms of COVID-19.

General Dermatology

Disparities “Negate” 7-Vaccine Series Rate Increases, Study Says

Cassandra Pardini, PharmD

April 28, 2021

The 7-vaccine series provides immunization against diphtheria, pertussis, tetanus, poliovirus, measles, mumps, rubella, hepatitis b, Haemophilus influenze type b, varicella, and pneumococcal infections.

General Dermatology

Rash Following Medication Change Prompts Evaluation of Excipient Allergy

Cassandra Pardini, PharmD

April 27, 2021

The patient developed a generalized maculopapular rash approximately 3 hours after receiving warfarin.

General Dermatology

Case Report: Pain Med Dose Linked to Patient’s Sleepwalking

Cassandra Pardini, PharmD

April 23, 2021

The patient, who had suffered a traumatic brain injury approximately 8 months prior, presented to the emergency department complaining of increasing dizziness as well as sleepwalking frequency.

Practice Management

Case Series: Naloxone Use Linked to Acute Pulmonary Edema

Cassandra Pardini, PharmD

April 9, 2021

At normal doses, the drug’s adverse effects are minimal, with the majority being attributed to acute withdrawal effects.

Practice Management

Most Individuals Complete COVID-19 Vaccine Series, Says Report

Cassandra Pardini, PharmD

March 26, 2021

The recommended time interval between the 2 doses is 21 days for the Pfizer-BioNTech vaccine and 28 days for the Moderna vaccine; however, if a delay is unavoidable, 42 days between doses is considered permissible.

Practice Management

Case Series Describes Use of Icosapent Ethyl for COVID-19 Pneumonia

Cassandra Pardini, PharmD

January 8, 2021

The authors described the cases of 3 patients with moderate to severe COVID-19 pneumonia who were treated with 2g of icosapent ethyl administered twice daily via a nasogastric tube.

Practice Management

Pet Meds Listed in Owner’s Medication Profile Lead to Confusion in the ED

Cassandra Pardini, PharmD

December 8, 2020

The patient, a 67-year-old female, presented to the emergency department with altered mental status.

Next post in Practice Management